3-Chloro-4-fluoro-5-nitrobenzotrifluoride - CAS 101646-02-0
Catalog: |
BB000576 |
Product Name: |
3-Chloro-4-fluoro-5-nitrobenzotrifluoride |
CAS: |
101646-02-0 |
Synonyms: |
1-chloro-2-fluoro-3-nitro-5-(trifluoromethyl)benzene |
IUPAC Name: | 1-chloro-2-fluoro-3-nitro-5-(trifluoromethyl)benzene |
Description: | 3-Chloro-4-fluoro-5-nitrobenzotrifluoride can be used as pyrolyl-tRNA synthetase inhibitors. It can also be used to treat various diseases, including nervous and mental disorders and inflammatory diseases, caused by abnormal intracellular signaling, that can include acetylcholine. |
Molecular Weight: | 243.54 |
Molecular Formula: | C7H2ClF4NO2 |
Canonical SMILES: | C1=C(C=C(C(=C1[N+](=O)[O-])F)Cl)C(F)(F)F |
InChI: | InChI=1S/C7H2ClF4NO2/c8-4-1-3(7(10,11)12)2-5(6(4)9)13(14)15/h1-2H |
InChI Key: | JVOKKJHIEVEFEB-UHFFFAOYSA-N |
Boiling Point: | 200 °C |
Melting Point: | 200 °C (lit.) |
Purity: | 95 % |
Density: | 1.607 g/mL at 25 °C (lit.) |
Appearance: | Colorless solid |
Storage: | Sealed in dry, Room Temperature |
MDL: | MFCD00674108 |
LogP: | 3.92930 |
GHS Hazard Statement: | H302 (11.63%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CA-3049643-A1 | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | 20170207 |
JP-2020506197-A | Novel heterocyclic compound, production method thereof and pharmaceutical composition containing the same | 20170207 |
KR-102084772-B1 | Novel hetero-ring compound, its preparation method, and pharmaceutical composition comprising the same | 20170207 |
KR-20180091770-A | Novel hetero-ring compound, its preparation method, and pharmaceutical composition comprising the same | 20170207 |
TW-201831463-A | Novel heterocyclic compound, preparation method thereof and pharmaceutical composition containing the same | 20170207 |
Complexity: | 254 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 242.9710186 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 242.9710186 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 45.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Fluorinated Building Blocks
-
[1427357-61-6]
6-Fluoro-[1,2,4]triazolo[1,5-a]pyridine
-
[1106917-71-8]
[3-(Difluoromethoxy)phenyl]methanamine hydrochloride
-
[2454490-85-6]
2-(7,8-Difluoro-1-naphthyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
-
[865774-78-3]
2-(6,8-difluoro-1,2,3,4-tetrahydro-naphthalen-2-ylamino)-pentanoic acid methyl ester
-
[351-28-0]
3'-Fluoroacetanilide
-
[51516-70-2]
5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carbonitrile
Nitrogen Compounds
Other Pyrimidines
-
[2367-82-0]
1,2,3,5-Tetrafluorobenzene
-
[1183749-69-0]
2-(pyrimidin-2-yloxy)phenol
-
[937601-34-8]
3-Bromo-2,5-dimethylpyrazolo[1,5-a]pyrimidine-7-carboxylic acid
-
[832739-73-8]
4-(3,5-Dichlorophenyl)pyrimidine-2-thiol
-
[1632145-37-9]
3-Methyl-3-(perfluoropyridin-4-yl)-1,5-dioxaspiro[5.5]undecane-2,4-dione
-
[1489-53-8]
1,2,3-Trifluorobenzene
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS